TBPH
Theravance Biopharma Inc
17.00$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Theravance Biopharma Inc (TBPH) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/23/2026 | Current report (8-K) | Theravance Biopharma, Inc. (TBPH): Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Material Modifications to Rights of Security Holders; Changes in Control of Registrant; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorpo | View report ↗ |
| 09/18/2026 | Current report (8-K) | Theravance Biopharma, Inc. (TBPH): Submission of Matters to a Vote of Security Holders | View report ↗ |
| 09/15/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 09/10/2026 | Current report (8-K) | Theravance Biopharma, Inc. (TBPH): Other Events | View report ↗ |
| 08/25/2026 | Current report (8-K) | Theravance Biopharma, Inc. (TBPH): Other Events; Financial Statements and Exhibits | View report ↗ |
| 08/10/2026 | Current report (8-K) | Theravance Biopharma, Inc. (TBPH): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.